» Articles » PMID: 33145726

Dysmetabolic Adipose Tissue in Obesity: Morphological and Functional Characteristics of Adipose Stem Cells and Mature Adipocytes in Healthy and Unhealthy Obese Subjects

Overview
Publisher Springer
Specialty Endocrinology
Date 2020 Nov 4
PMID 33145726
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The way by which subcutaneous adipose tissue (SAT) expands and undergoes remodeling by storing excess lipids through expansion of adipocytes (hypertrophy) or recruitment of new precursor cells (hyperplasia) impacts the risk of developing cardiometabolic and respiratory diseases. In unhealthy obese subjects, insulin resistance, type 2 diabetes, hypertension, and obstructive sleep apnoea are typically associated with pathologic SAT remodeling characterized by adipocyte hypertrophy, as well as chronic inflammation, hypoxia, increased visceral adipose tissue (VAT), and fatty liver. In contrast, metabolically healthy obese individuals are generally associated with SAT development characterized by the presence of smaller and numerous mature adipocytes, and a lower degree of VAT inflammation and ectopic fat accumulation. The remodeling of SAT and VAT is under genetic regulation and influenced by inherent depot-specific differences of adipose tissue-derived stem cells (ASCs). ASCs have multiple functions such as cell renewal, adipogenic capacity, and angiogenic properties, and secrete a variety of bioactive molecules involved in vascular and extracellular matrix remodeling. Understanding the mechanisms regulating the proliferative and adipogenic capacity of ASCs from SAT and VAT in response to excess calorie intake has become a focus of interest over recent decades. Here, we summarize current knowledge about the biological mechanisms able to foster or impair the recruitment and adipogenic differentiation of ASCs during SAT and VAT development, which regulate body fat distribution and favorable or unfavorable metabolic responses.

Citing Articles

miR-6402 targets and negatively regulates mouse adipogenesis.

Elsheikh M, Sano T, Mizokami A, Nakatsu Y, Asano T, Kanematsu T Adipocyte. 2025; 14(1):2474114.

PMID: 40028748 PMC: 11881869. DOI: 10.1080/21623945.2025.2474114.


An integrated view of the pathophysiological crosstalk between adipose tissue, bone and cardiovascular system in men and women.

Klinaku F, Comi L, Giglione C, Magni P J Endocrinol Invest. 2024; .

PMID: 39692990 DOI: 10.1007/s40618-024-02516-x.


Weighted vest intervention during whole-body circuit training improves serum resistin, insulin resistance, and cardiometabolic risk factors in normal-weight obese women.

Kim J, Kim E, Kim D, Yoon S J Exerc Sci Fit. 2024; 22(4):463-473.

PMID: 39525516 PMC: 11550068. DOI: 10.1016/j.jesf.2024.10.002.


Dynamics of single-nuclei transcriptomic profiling of adipose tissue from diverse anatomical locations during mouse aging process.

Wu Y, Sun Y, Chen L, Tong X, Liu C, Lu L Sci Rep. 2024; 14(1):16093.

PMID: 38997312 PMC: 11245496. DOI: 10.1038/s41598-024-66918-w.


Gut microbiota and fecal volatilome profile inspection in metabolically healthy and unhealthy obesity phenotypes.

Calabrese F, Genchi V, Serale N, Celano G, Vacca M, Palma G J Endocrinol Invest. 2024; 47(12):3077-3090.

PMID: 38904913 PMC: 11549234. DOI: 10.1007/s40618-024-02379-2.


References
1.
Perrini S, Cignarelli A, Ficarella R, Laviola L, Giorgino F . Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes?. Arch Physiol Biochem. 2009; 115(4):218-26. DOI: 10.1080/13813450903260864. View

2.
Arner P, Bernard S, Salehpour M, Possnert G, Liebl J, Steier P . Dynamics of human adipose lipid turnover in health and metabolic disease. Nature. 2011; 478(7367):110-3. PMC: 3773935. DOI: 10.1038/nature10426. View

3.
Spalding K, Arner E, Westermark P, Bernard S, Buchholz B, Bergmann O . Dynamics of fat cell turnover in humans. Nature. 2008; 453(7196):783-7. DOI: 10.1038/nature06902. View

4.
Pellegrinelli V, Carobbio S, Vidal-Puig A . Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia. 2016; 59(6):1075-88. PMC: 4861754. DOI: 10.1007/s00125-016-3933-4. View

5.
Perrini S, Cignarelli A, Quaranta V, Falcone V, Kounaki S, Porro S . Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea. JCI Insight. 2017; 2(17). PMC: 5621882. DOI: 10.1172/jci.insight.94379. View